PDF(Pubmed)
Abstract：
UNASSIGNED: This study assessed the effects of Aloe vera supplementation on serum inflammatory factors, blood sugar and lipid profiles in hemodialysis patients.
UNASSIGNED: Totally, 50 hemodialysis patients were allocated randomly to either Aloe vera or placebo groups. The Aloe vera group received 2 Aloe vera capsules daily for 8 weeks (500 mg/day). Serum C-reactive protein (hs- CRP), Fasting blood glucose (FBS), and lipid profiles levels were evaluated at the baseline and the end of the eighth week.
UNASSIGNED: Aloe vera supplementation for 8 weeks was associated with a significant reduction of serum hs- CRP (p=0.004), total cholesterol (p=0.01), low density lipoprotein (LDL) (p=0.02) leves and increased high density lipoprotein (HDL) (p=0.002) concentration in the hemodialysis patients.
UNASSIGNED: Aloe vera supplementation is beneficial in improvement of cardiovascular risk factors in hemodialysis patients.
UNASSIGNED: Totally, 50 hemodialysis patients were allocated randomly to either Aloe vera or placebo groups. The Aloe vera group received 2 Aloe vera capsules daily for 8 weeks (500 mg/day). Serum C-reactive protein (hs- CRP), Fasting blood glucose (FBS), and lipid profiles levels were evaluated at the baseline and the end of the eighth week.
UNASSIGNED: Aloe vera supplementation for 8 weeks was associated with a significant reduction of serum hs- CRP (p=0.004), total cholesterol (p=0.01), low density lipoprotein (LDL) (p=0.02) leves and increased high density lipoprotein (HDL) (p=0.002) concentration in the hemodialysis patients.
UNASSIGNED: Aloe vera supplementation is beneficial in improvement of cardiovascular risk factors in hemodialysis patients.
摘要：
■本研究评估了补充芦荟对血清炎症因子的影响，血液透析患者的血糖和血脂状况。
■完全,将50名血液透析患者随机分为芦荟组或安慰剂组。芦荟组每天服用2粒芦荟胶囊，共8周（500mg/天）。血清C反应蛋白(hs-CRP),空腹血糖（FBS），在基线和第8周结束时评估血脂水平.
■补充芦荟8周与血清hs-CRP显着降低有关（p=0.004），总胆固醇（p=0.01），血液透析患者低密度脂蛋白（LDL）（p=0.02）升高，高密度脂蛋白（HDL）浓度升高（p=0.002）。
■补充芦荟有利于改善血液透析患者的心血管危险因素。
■完全,将50名血液透析患者随机分为芦荟组或安慰剂组。芦荟组每天服用2粒芦荟胶囊，共8周（500mg/天）。血清C反应蛋白(hs-CRP),空腹血糖（FBS），在基线和第8周结束时评估血脂水平.
■补充芦荟8周与血清hs-CRP显着降低有关（p=0.004），总胆固醇（p=0.01），血液透析患者低密度脂蛋白（LDL）（p=0.02）升高，高密度脂蛋白（HDL）浓度升高（p=0.002）。
■补充芦荟有利于改善血液透析患者的心血管危险因素。
